Comments

Vir Biotechnology Stock Price, Quotes and Forecasts

Q: What sector and industry does Vir Biotechnology (VIR) operate in?

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VIRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.73

0.091.94%

At close: -

$4.73

0.000.00%

After Hours: 6:42 PM EDT

Vir Biotechnology (VIR) Forecast

News Earnings Vir Biotechnology (VIR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Vir Biotechnology Stock Price, Quotes and Forecasts | NASDAQ:VIR | Benzinga

Explore Vir Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIR.

Open	$4.63
Close	$4.73
Volume / Avg.	1.51M / 1.30M
Day Range	$4.52 - $4.85
52 Wk Range	4.32 - 14.45
Market Cap	$653.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	12.06%
Days to Cover	11.32

Recent News

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.

Vandana Singh

Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why

Vir Biotechnology's Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and PSMA in cancer therapies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.63
Close	$4.73
Volume / Avg.	1.51M / 1.30M
Day Range	$4.52 - $4.85
52 Wk Range	4.32 - 14.45
Market Cap	$653.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	12.06%
Days to Cover	11.32

About Vir Biotechnology Inc

Sector

Health Care

Industry

Biotechnology

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to tre...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vir Biotechnology (VIR) stock?

You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Who are Vir Biotechnology (VIR) competitors?

Other companies in Vir Biotechnology’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Vir Biotechnology (VIR) stock?

Vir Biotechnology has a consensus price target of $30.45.

What is the current price for Vir Biotechnology (VIR)?

The stock price for Vir Biotechnology (NASDAQ: VIR) is $4.73 last updated May 20, 2025 at 6:42 PM EDT.

Does Vir Biotechnology (VIR) pay a dividend?

There are no upcoming dividends for Vir Biotechnology.

When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?

Vir Biotechnology’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Vir Biotechnology (VIR) going to split?

There is no upcoming split for Vir Biotechnology.

What sector and industry does Vir Biotechnology (VIR) operate in?

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.